151 related articles for article (PubMed ID: 15183247)
1. Detection of prion after decontamination procedures: comparative study of standard Western blot, filter retention and scrapie-cell assay.
Solassol J; Arlotto M; Lehmann S
J Hosp Infect; 2004 Jun; 57(2):156-61. PubMed ID: 15183247
[TBL] [Abstract][Full Text] [Related]
2. Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates.
Sowemimo-Coker SO; Pesci S; Andrade F; Kim A; Kascsak RB; Kascsak RJ; Meeker C; Carp R
Vox Sang; 2006 May; 90(4):265-75. PubMed ID: 16635068
[TBL] [Abstract][Full Text] [Related]
3. Removal of exogenous (spiked) and endogenous prion infectivity from red cells with a new prototype of leukoreduction filter.
Sowemimo-Coker S; Kascsak R; Kim A; Andrade F; Pesci S; Kascsak R; Meeker C; Carp R; Brown P
Transfusion; 2005 Dec; 45(12):1839-44. PubMed ID: 16371036
[TBL] [Abstract][Full Text] [Related]
4. A novel copper-hydrogen peroxide formulation for prion decontamination.
Solassol J; Pastore M; Crozet C; Perrier V; Lehmann S
J Infect Dis; 2006 Sep; 194(6):865-9. PubMed ID: 16941355
[TBL] [Abstract][Full Text] [Related]
5. Extended period of asymptomatic prion disease after low dose inoculation: assessment of detection methods and implications for infection control.
Collins SJ; Lewis V; Brazier MW; Hill AF; Lawson VA; Klug GM; Masters CL
Neurobiol Dis; 2005 Nov; 20(2):336-46. PubMed ID: 16242640
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of removal of prion infectivity from red blood cells with prion reduction filters using a new rapid and highly sensitive cell culture-based infectivity assay.
Sowemimo-Coker SO; Demczyk CA; Andrade F; Baker CA
Transfusion; 2010 May; 50(5):980-8. PubMed ID: 20003057
[TBL] [Abstract][Full Text] [Related]
7. Investigations of a prion infectivity assay to evaluate methods of decontamination.
Fichet G; Comoy E; Dehen C; Challier L; Antloga K; Deslys JP; McDonnell G
J Microbiol Methods; 2007 Sep; 70(3):511-8. PubMed ID: 17640752
[TBL] [Abstract][Full Text] [Related]
8. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
[TBL] [Abstract][Full Text] [Related]
9. Effect of drying time, ambient temperature and pre-soaks on prion-infected tissue contamination levels on surgical stainless steel: concerns over prolonged transportation of instruments from theatre to central sterile service departments.
Lipscomb IP; Pinchin H; Collin R; Keevil CW
J Hosp Infect; 2007 Jan; 65(1):72-7. PubMed ID: 17145104
[TBL] [Abstract][Full Text] [Related]
10. Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion.
Pan T; Li R; Kang SC; Wong BS; Wisniewski T; Sy MS
J Neurochem; 2004 Sep; 90(5):1205-17. PubMed ID: 15312175
[TBL] [Abstract][Full Text] [Related]
11. New hospital disinfection processes for both conventional and prion infectious agents compatible with thermosensitive medical equipment.
Lehmann S; Pastore M; Rogez-Kreuz C; Richard M; Belondrade M; Rauwel G; Durand F; Yousfi R; Criquelion J; Clayette P; Perret-Liaudet A
J Hosp Infect; 2009 Aug; 72(4):342-50. PubMed ID: 19541387
[TBL] [Abstract][Full Text] [Related]
12. Acetone precipitation of the scrapie agent results in successful recovery of PrP(Sc) but decreased infectivity.
Smith JD; Greenlee JJ; Foster GH; Nicholson EM
J Agric Food Chem; 2012 May; 60(18):4758-62. PubMed ID: 22519670
[TBL] [Abstract][Full Text] [Related]
13. Quantitative evaluation of prion inactivation comparing steam sterilization and chemical sterilants: proposed method for test standardization.
Vadrot C; Darbord JC
J Hosp Infect; 2006 Oct; 64(2):143-8. PubMed ID: 16895739
[TBL] [Abstract][Full Text] [Related]
14. Rapid method for the sensitive detection of protein contamination on surgical instruments.
Lipscomb IP; Sihota AK; Botham M; Harris KL; Keevil CW
J Hosp Infect; 2006 Feb; 62(2):141-8. PubMed ID: 16290315
[TBL] [Abstract][Full Text] [Related]
15. Novel methods for disinfection of prion-contaminated medical devices.
Fichet G; Comoy E; Duval C; Antloga K; Dehen C; Charbonnier A; McDonnell G; Brown P; Lasmézas CI; Deslys JP
Lancet; 2004 Aug 7-13; 364(9433):521-6. PubMed ID: 15302195
[TBL] [Abstract][Full Text] [Related]
16. Prion inactivation by the Maillard reaction.
Suyama K; Yoshioka M; Akagawa M; Murayama Y; Horii H; Takata M; Yokoyama T; Mohri S
Biochem Biophys Res Commun; 2007 Apr; 356(1):245-8. PubMed ID: 17336934
[TBL] [Abstract][Full Text] [Related]
17. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
18. An improved Western blot assay to assess the clearance of prion protein from plasma-derived therapeutic proteins.
Hartwell RC; Nelson MS; Kislan MM; Stenland CJ; Miller JL; Pifat DY; Petteway SR; Cai K
J Virol Methods; 2005 May; 125(2):187-93. PubMed ID: 15794989
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a proteolytic enzyme derived from a Bacillus strain that effectively degrades prion protein.
Yoshioka M; Miwa T; Horii H; Takata M; Yokoyama T; Nishizawa K; Watanabe M; Shinagawa M; Murayama Y
J Appl Microbiol; 2007 Feb; 102(2):509-15. PubMed ID: 17241357
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
